Demetrix Is Scaling The Cannabinoid Industry Demetrix has commenced 15,000-liter demo-scale fermentation production of CBG, the first rare cannabinoid it will take to market. It's a big step towards the commercialization of cannabinoids for a range of safe, effective, and legal health and wellness products, from pharmaceuticals to skincare.